Key Metrics
11.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
10 - 15
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.86
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
2.52
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Amyloidosis
- Proteasome
- Overall survival
- Plasma cell leukemia
- Minimal residual disease
- B-cell lymphoma
- Functional validation
- Diffuse large B-cell lymphoma
- Monoclonal antibody
- Lenalidomide
- Immunotherapy
- Daratumumab
- Refractory Multiple Myeloma
- Observational study
- Monoclonal gammopathy of undetermined significance
- Poor prognosis
- Creatinine
- Thrombosis
- Genetic complexity
- T-cell leukemia
Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3790 | USD 4790 | GBP 3290 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 14 |
| Article Processing Charges | EUR 3790 | USD 4790 | GBP 3290 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in Blood Cancer Journal ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells.
- 1 Dec 14
- Blood cancer journal
-
Full paper
A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation.
- 1 Dec 14
- Blood cancer journal
-
Full paper
Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.
- 1 Dec 14
- Blood cancer journal
-
Full paper
Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor.
- 1 Dec 14
- Blood cancer journal
-
Full paper
Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
- 1 Dec 14
- Blood cancer journal
-
Full paper
Definition and management of ruxolitinib treatment failure in myelofibrosis.
- 1 Dec 14
- Blood cancer journal
Scite analysis
Powered by scite_
1.6k articles received 35.6k citations see all
- 1,619 Supporting
- 33,259 Mentioning
- 204 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 27 Corrections
- 39 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
40%
4 to 6 months
49%
7 to 9 months
10%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Blood Cancer Journal been actively publishing?
Blood Cancer Journal has been in operation since 2011 till date.
What is the publishing frequency of Blood Cancer Journal ?
Blood Cancer Journal published with a Continuous publication frequency.
How many articles did Blood Cancer Journal publish last years ?
In 2023, Blood Cancer Journal published articles.
What is the eISSN & pISSN for Blood Cancer Journal ?
For Blood Cancer Journal,eISSN is 2044-5385 and pISSN is2044-5385.
What is Citescore for Blood Cancer Journal ?
Citescore for Blood Cancer Journal is 11.8.
What is SNIP score for Blood Cancer Journal ?
SNIP score for Blood Cancer Journal is 2.52.
What is the SJR for Blood Cancer Journal ?
SJR for Blood Cancer Journal is Q1.
Who is the publisher of Blood Cancer Journal ?
SPRINGERNATURE is the publisher of Blood Cancer Journal.